ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Spitz elected President, ASPO: Karmanos Received $6 Million From Chrysler, Ford

May 30, 1997

Funding opportunties listed.

December 3, 2004

Lasker Pushes NCI To Get Research Results Quicker, Into Practice Sooner

May 31, 1974

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993

Intense Therapies Better Than Lower Dose For AML

November 26, 2004

ASCO Seeks “Nothing Less Than A Smoke-Free World”

June 6, 2003